By Heather Hawkins
24 May 2021
Even today – and it’s been 14 years since diagnosis – they still evoke a very raw and deeply emotional response. It was the first time I’d faced the undeniable fact […]
Four Australian women are diagnosed with ovarian cancer a day and three will eventually die from the disease. It’s usually diagnosed late, because few women show symptoms until they have advanced cancer.
As a junior doctor in London in the mid-1980s, Ian Jacobs saw women undergo chemo and […]
By Leigh Dayton
4 March 2021
In 1966 Alan Trounson was enjoying a hike in the hills above Edinburgh, Scotland with his colleague Ian Wilmut when Wilmut revealed a secret. His team at the Roslin Institute had cloned a […]
A survey reveals nearly US$100 market capitalisation
23 February 2021
A survey conducted by Washington DC based BioInformant assesses the growth of the CAR-T arm of immunotherapy research and development. The summary is posted below.
At first the trend was subtle, but the tide has swelled as CAR-T therapies like Kymriah, Yescarta, Tecartus, and […]
By Leigh Dayton
4 February 2021
Not only is Alan Trounson Cartherics CEO and a leader in embryonic stem cell science, he’s also a pioneer in IVF technology. Back in 1980 the then embryologist made headlines for his participation in the birth of Australia’s first IVF baby, Candice Reed.
Thanks to this […]
Back People Not Projects
By Ian Nisbet*
“If plan A doesn’t work, the alphabet has 25 more letters – 46 if you’re in Japan.” (Claire Cook, Seven Year Switch)
In the late 1980s and early 1990s I was working at CSL during the years leading up to its public listing and prior to it becoming the behemoth it […]
18 November 2020
By Leigh Dayton
They may not be able to gather at the Melbourne Convention Centre this year, but global experts in immunotherapy will swap ideas December 15 & 16 as Eradicate Cancer 2020 goes virtual.
Taking on the role of conference convenor for the second time, after the highly successful inaugural Conference in 2018, […]
Genetic scissors: a tool for rewriting the code of life wins the 2020 Nobel Prize for Chemistry
The Royal Swedish Academy of Sciences
7 October 2020
Using these tools, researchers can change the DNA of animals, plants and microorganisms with […]
View the article in the CRC (Cooperative Research Centres Association) Association Newsletter here : CRC Association Newsletter
Cartherics’ cost-effective ‘off-the-shelf’ ovarian cancer therapy made from special donor umbilical cord blood samples is in the final stages of preclinical development.
By combining immunotherapy and stem cell research, we can manufacture Natural Killer (NK) cells that carry a […]
Along with others Alan shares his experience in this short clip ………
We're celebrating 40 years of the GSK Award for Research Excellence (ARE) with support from our esteemed alumni.
Some of our past winners took time out in #lockdown to reflect on the impact of the ARE on their work & the importance of supporting Aussie research. #40YearsOfARE pic.twitter.com/cI67CeUpVo
— GSK Australia (@GSK_AU) September 2, 2020
Cartherics’ mission is the development of novel, “off-the-shelf” (allogeneic) immune cell therapy products for the treatment of cancer.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
